Johnson & Johnson closes $2bn LifeScan sale
Johnson & Johnson (J&J) has closed the $2.1billion sale of its LifeScan blood glucose monitoring subsidiary to private equity player Platinum Equity. The sale is part of the
Johnson & Johnson (J&J) has closed the $2.1billion sale of its LifeScan blood glucose monitoring subsidiary to private equity player Platinum Equity. The sale is part of the
People living with diabetes in Europe now have the choice to be alerted in real-time of hypoglycaemia (low glucose levels) or hyperglycaemia (high glucose levels)
A new £1.5m digital pharmacy has opened in Liverpool, aimed at helping people living with chronic care conditions to manage their medicinal needs through artificial
As reported by Business Insider in late August, Dexcom announced that it had acquired TypeZero Technologies, Inc. TypeZero’s offering includes the inControl diabetes management system,
Professor John Pickup has been involved in diabetes care for most of his career in medicine. He’s been there from the beginning, when continuous subcutaneous
In this issue we look at what you need to know about coeliac disease and gluten intolerance. There’s news (from p.4) about Dexcom buying TypeZero
Dr Harry Destecroix, 31, co-founded Ziylo while studying for his PhD at the University of Bristol four years ago. It created a new technology that
JDRF, the leading global organisation funding type 1 diabetes research, has appointed internationally renowned cellist Sheku Kanneh-Mason as a global ambassador. The 19 year-old British cellist
If you wanted an added bit of peace of mind when carrying a vial of insulin with you, try this little security blanket which can
This handy little item is new from the folk at Frio. Small enough to get you through a few days or maybe a week or